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MGME1, alsoknownasDdk1orC20orf72, is amitochondrial exonuclease found tobe involved in theprocessing
of mitochondrial DNA (mtDNA) during replication. Here, we present detailed insights on the role of MGME1 in
mtDNA maintenance. Upon loss of MGME1, elongated 7S DNA species accumulate owing to incomplete pro-
cessingof 5′ ends.Moreover, an11-kb linearmtDNA fragment spanning theentiremajor arcof themitochondrial
genome is generated. In contrast to control cells, where linearmtDNAmolecules are detectable only after nucle-
ase S1 treatment, the 11-kb fragment persists in MGME1-deficient cells. In parallel, we observed characteristic
mtDNA duplications in the absence of MGME1. The fact that the breakpoints of these mtDNA rearrangements
do not correspond to either classical deletions or the ends of the linear 11-kb fragment points to a role of
MGME1 in processingmtDNAends, possibly enabling their repair by homologous recombination. In agreement
with its functional involvement in mtDNAmaintenance, we show that MGME1 interacts with the mitochondrial
replicase PolgA, suggesting that it is a constituent of the mitochondrial replisome, to which it provides an add-
itionalexonucleaseactivity.Thus,our resultssupport theviewpoint thatMGME1-mediatedmtDNAprocessing is
essential for faithfulmitochondrial genome replication andmight be required for intramolecular recombination
of mtDNA.
INTRODUCTION
It has been proposed thatmammalianmitochondria operatemul-
tiplemechanisms of replication, and each of thesemodels would
benefit from further corroboration (1). The initially proposed
model (the ‘strand-displacement model’) assumes that repli-
cation of mitochondrial DNA (mtDNA) involves only two
priming events (one per strand), using a single replicase, Polg
(a holoenzyme composed of the catalytic subunit PolgA and
accessorysubunitPolgB).Replicationof theheavystrand initiates
at a specific site in themtDNA non-coding region (NCR) known
as OH. DNA synthesis is continuous and proceeds by displacing
approximately two-thirds of the length of mtDNA, before OL is
exposed and continuous light-strand synthesis is initiated (2).
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According to thismodel, thedisplacedH-strand is proposed to be
coated with ssDNA-binding protein (mtSSB). It was later pro-
posed that RNA, rather than protein, is used to coat the displaced
H-strand, and this is known as the ‘RITOLSmodel’ (3,4). In add-
ition, thorough analysis of mtDNA replication intermediates by
two-dimensional agarose gel electrophoresis has revealed struc-
tures typical of conventional bidirectional replication (5). The
NCR of many mtDNAmolecules contains a short displacement
loop region (D-loop), formed by the presence of a third DNA
strand known as 7S DNA. 7S DNA synthesis is believed to be
primed by a transcript originating from the light-strand promoter
(LSP), which undergoes a transition from RNA to DNA synthe-
sis downstream fromLSP. Themain 5′ ends of 7SDNAcoincide
with OH, and so this ssDNA species is often considered as a
product of prematurely terminated replication initiated at OH
(Fig. 1A). However, the exact role of 7S DNA is unknown (9).
Genetic diseases that are associated with failures of mtDNA
replication, collectively known asmitochondrial DNAmainten-
ance disorders, have helped to provide deeper insights into the
mechanism of mtDNA replication. The main features of these
disorders are either decreased mtDNA copy number (depletion)
or the presence of multiple mtDNA deletions, and very often a
combination of both (10). This group of diseases is caused by
mutations in nuclear genes that code for proteins involved in
mitochondrial genome maintenance. Pathogenic mutations
have been described either in genes that are essential formtDNA
synthesis, namely POLG (11), POLG2 (12), C10orf2 (13) and
possibly DNA2 (14) or in those involved in the mitochondrial
biosynthesis pathways of deoxyribonucleoside-5′-triphosphates
(15–20). For some mtDNA maintenance disorders, the patho-
mechanism has yet to be fully determined (21–24). Recently,
we discovered that in addition to the protein products of
POLG, POLG2 and C10orf2, a highly conserved mitochondrial
proteinwith exonuclease activity,MGME1(alsoknownasDdk1
or C20orf72), is required for proper mtDNA replication (25).
Loss of function mutations in MGME1, which abolish expres-
sion of the protein in patient cells, resulted in the apparent accu-
mulation of unusually large deletions, a reduction of mtDNA
copy number and the accumulation of replication intermediates
and of 7SDNA.We showed thatMGME1 belongs to the PD-(D/
E)XK nuclease superfamily and is a close homologue of the
bacterial RecB nuclease involved in DNA recombination. We
also provided evidence that MGME1 preferentially degrades
ssDNA (over dsDNA) in both 5′  3′ and 3′  5′ directions
and is capable of processing DNA flap and RNA–DNA flap
intermediates formed during mtDNA synthesis (25) and is
involved in the maintenance of proper 7S DNA levels (25,26).
The ability of MGME1 to process RNA primers from flap struc-
tures resembling replication intermediates is directly relevant to
all current models of mtDNA replication. The observation that
the levels of 7SDNA aremodified by changes inMGME1 activ-
ity may be a further important contribution to this puzzle.
In this work, we find that loss of MGME1 activity leads to (i)
lengthening of 7S DNA owing to incomplete processing of 5′
ends, (ii) the accumulation of an 11-kb linear mtDNA fragment,
a by-product of mtDNA replication originating from chromo-
some breakage at fragile sites and (iii) accumulation of
unusual mtDNA rearrangements (mostly partial duplications).
Homologous recombination-dependent DNA repair has been
proposed to be involved in the formation of classical deletions
in the mtDNA major arc (27). In MGME1-deficient cells,
however, only atypical clusters of breakpoints of rearranged
mtDNA molecules occur, suggesting that homologous recom-
bination is impaired in these cells. Finally, we show that
MGME1 interacts with the mitochondrial replicase PolgA, indi-
cating that it is an additional constituent of the mitochondrial
replisome that provides itwith a previously not described exonu-
cleolytic activity.
RESULTS
Modified DNA 5′ termini in the mtDNA non-coding region
of MGME1-deficient cells
Previously, we observed increased levels of 7S DNA in muscle
tissues and fibroblasts from patients harbouring a homozygous
stop mutation in the MGME1 gene (25) as well as in cells sub-
jected to siRNA down-regulation of MGME1 (25,26). Given
that MGME1 is a nuclease, this result suggested that the
enzyme is involved in the turnover of this molecule. In order
to verify this hypothesis, we compared the half-lives of 7S
DNA in fibroblasts fromMGME1-mutated patients and controls
upon inhibition of DNA synthesis using dideoxycytidine (ddC)
(Fig. 1B). We observed a reduced rate of 7S DNA decay in
MGME1-null fibroblasts in comparison with controls (Fig. 1B
and Supplementary Material, Table S1). Next, 7S DNA decay
wasmeasured in control andMGME1-null fibroblasts upon add-
ition of ethidium bromide (EtBr). EtBr rapidly inhibits mito-
chondrial transcription that is required for initial steps of 7S
biosynthesis (Fig. 1A). EtBr treatment led to a fast 7S DNA
decay in control cells; however, the degradation rate was mark-
edly reduced in MGME1-null fibroblasts (Supplementary Ma-
terial, Fig. S1). This suggests that the degradation of 7S DNA,
rather than its synthesis, is impaired in MGME1-deficient cells.
We hypothesized that if 7S DNA is a substrate of MGME1,
then a deficiency of MGME1 should result in altered processing
of 7SDNA.Toverify this,we performedprimer extension (PEx)
analysis of DNA 5′ ends in the NCR of MGME1-null patient
fibroblasts (FB1976) (Fig. 1C). All DNA samples were treated
with RNase A prior to PEx to remove potential 5′ RNA
leaders. The PEx primer annealed at the NCR downstream
from previously identified DNA 5′ ends (mtDNA positions 16
569–18) (6) and was extended towards LSP (Fig. 1A). PEx ana-
lysis of DNA from the P1976 fibroblasts showedmore abundant
extended species with 5′ ends upstream from the previously
observed ends (Fig. 1C), consistent with defects in the process-
ing of 5′ termini of 7S DNA. The presence of elongated 7S
DNA 5′ ends was confirmed by ligation-mediated (LM) PCR
(Fig. 1D, arrowheads and Supplementary Material, Fig. S2A).
In addition, we used LM-PCR to investigate 3′ ends of 7S
DNA. We found no changes at the 3′ end of 7S DNA upon loss
of MGME1 activity in comparison with controls (Fig. 1E), con-
sistent with the ability ofMGME1 to catalyse an 5′  3′ exonu-
cleolytic reaction as reported previously (25,26).
Under the assumption that the synthesis of 7SDNA is initiated
by transcription fromLSP followed by anRNA–DNA transition
downstream from LSP, we examined whether inactivation of
MGME1 affects the processing of RNA at the 5′ end of 7S
DNA. To this end, we performed PEx on DNA samples that
were not treated with RNase A during the isolation procedure
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(Supplementary Material, Fig. S3). The DNA polymerase used
for PEx can perform reverse transcription of an RNA template
if primed on a DNA template, so any RNA covalently attached
to the 5′ ends of DNA should also be extended (Supplementary
Material, Fig. S3A). We did not detect any extra ends in P1976
fibroblast samples that were not treated with RNase A compared
with those present in the same samples treated with RNase A
(Fig. 1C and Supplementary Material, Fig. S3B). Furthermore,
pre-treatment of fibroblast DNA with RNase H1 (which specif-
ically degrades the RNA strand of RNA–DNA hybrids) prior to
PEx produced an extraminor band at CSB2 in both control fibro-
blasts and FB1976 (Supplementary Material, Fig. S3B). This
species has been previously observed after RNase H1 treatment
of mtDNA (6,7) and is believed to represent transcription events
initiating from LSP and terminating at CSB2. These results
suggest that the RNA–DNA transition is not affected in
MGME1-null cells and that the enzyme takes part in DNA pro-
cessing downstream from the transition site.
Inorder to seewhether partial inactivationofMGME1expres-
sion also has an effect on the processing of 7S DNA, we per-
formed siRNA silencing of MGME1 in HeLa cells followed
by analogous PEx examination of DNA 5′ ends in the NCR
region. MGME1 protein levels were efficiently reduced by the
siRNA treatment, being undetectable bywestern blotting follow-
ing 6 days of transfection (Supplementary Material, Fig. S3C).
This analysis confirmed the existence of the previously observed
Figure 1.Loss ofMGME1modifies the 5′ ends ofDNAspecies in theNCR. (A) The humanmitochondrial NCR. The position of themain 5′ ends of 7SDNA found in
this and other studies (6–8) are indicated. HSP andLSP—heavy- and light-strand promoter, respectively. CSB—conserved sequence block, TAS—termination asso-
ciated sequences. Positions of primers used in thePEx andLM-PCRanalysis are given. (B) 7SDNA levels in control and patient fibroblasts quantifiedbyqPCRduring
ddC treatment for the indicated time (grey bar). Two controls and two patient samples were investigated, each determined in three independent reactions. Half-life
times were determined by nonlinear regression analysis of qPCR data assuming simple exponential decay kinetics (inset). (C) Primer extension mapping of DNA 5′
ends in humancontrol andpatientfibroblasts (FB1976).A radioactively labelledprimer annealing at nt position16 569–18of humanmtDNAwasextendedusing total
DNApreparations treatedwith RNaseA during cell lysis. (D) DNA 5′ ends detected by LM-PCR in controls and FB1976. Further details are provided in Supplemen-
taryMaterial, FigureS2. (E)DNA3′ ends in thevicinityof theTASsequencedetectedbyLM-PCRinhumancontrol andpatientfibroblast (FB1976). (F) PExmapping
of DNA 5′ ends in the humanmtDNANCR ofHeLa cells transfected with siRNA toMGME1 or siRNA to GFP for 3 or 6 days. The experiment was performed as per
(C). ‘Untr’—non-transfected control.
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DNA 5′ ends in the NCR, as well as revealing more abundant
species with 5′ ends upstream from the known termini in
MGME1 siRNA-transfected cells (Fig. 1F).
Overexpression of MGME1 reduces the steady-state levels
of 7S DNA and shortens 7S DNA 5′ ends
In order to establish whether elevated levels of MGME1 affect
mtDNA metabolism, and in particular the level and length of
7S DNA, we overexpressed recombinant MGME1 or the
K253A catalytic mutant (both tagged with Strep2 and Flag)
(25) in HEK293T cells in a time course of 4 days (Fig. 2A). In
these conditions, overexpression of either the wild-type or
mutant MGME1 in HEK293T cells did not have any significant
effect onmtDNAcopynumber (Fig. 2B–D).This result is incon-
sistent with our previous report, where high overexpression
levels through a lentiviral system in human primary fibroblast
led to reduced mtDNA copy numbers (25). As the overexpres-
sion levels are comparable in both cell lines (Supplementary
Material, Fig. S4A), this effect is likely owing to different cell
types used and differences in the duration of overexpression
(days in the case of HEK293T cells, as opposed to several
weeks in the case of human fibroblasts). Despite unaltered
mtDNA copy numbers, there was an 50% reduction in the
steady-state level of 7S DNA in HEK293T cells overexpressing
thewild-type version ofMGME1 (Fig. 2B, left andC), but not in
cells overexpressing the K253A mutant (Fig. 2B, right and D).
An extended time course of MGME1 overexpression did not
cause any more pronounced effect upon 7S DNA steady-state
levels. However, we have noticed that these DNA species
appeared shorter in the MGME1 wild-type overexpressing
cells (Supplementary Material, Fig. S4B).
In order to test whether an overabundance of MGME1 also
causes shortening of 7S DNA owing to altered processing of 5′
ends, we performed PEx analysis within the NCR, as described
in the preceding section. This PEx analysis showed modified 5′
ends inDNAsamples fromHEK293Tcells overexpressingwild-
type MGME1, but not the K253A mutant. The intensity of PEx
bands corresponding to DNA ends upstream of position 111
was notably lower upon MGME1 wild-type overexpression
(Fig. 2E), consistent with the observed shortening observed in
Southern blotting analysis of the same samples (Supplementary
Material, Fig. S4B). An extended time course of MGME1 over-
expression didnot cause anymorepronouncedeffect on7SDNA
ends (Supplementary Material, Fig. S4C). The changes in 7S
DNA upon overexpression of wild-type MGME1 were further
documented by high-resolution Southern blotting (Fig. 2F).
Only the longest 7S DNA molecules, with 5′ ends upstream
from nt 117, were modified after overexpression of MGME1
wild-type, consistent with the results obtained in PEx analysis
(compare Fig. 2E and F). In summary, these results support the
proposed role of MGME1 in regulating the proper steady-state
levels of 7S DNA (25,26) and point towards its function in the
processing of the 5′ terminus of this molecule.
In vitro activity of MGME1 on D-loop DNA substrates
As the above-mentioneddata suggested thatMGME1operates at
the 5′ terminus of the mitochondrial D-loop region, we have
investigated the in vitro enzymatic properties of MGME1 on
D-loop-type DNA substrates. The recombinant protein was iso-
lated from human mitochondria by affinity purification as
described previously (25). As reported earlier, MGME1 effi-
ciently cleaves ssDNA (Supplementary Material, Fig. S5A,
first panel), but not dsDNA, and requires DNA ends in order to
initiate the reaction (25). We additionally tested whether the
enzyme is capable of cleaving displaced ssDNA in a DNA
bubble structure (Supplementary Material, Fig. S5A, second
panel). However, recombinantMGME1processed this substrate
with lowefficiency (SupplementaryMaterial, Fig. S5B, orange).
Next, we tested whetherMGME1 can process aD-loop strand (a
linear fragment that displaces one strand of dsDNA) in a D-loop
structure; such a strandwould correspond to7SDNAin themito-
chondrial NCR (Supplementary Material, Fig. S5A, four right
panels). The recombinant MGME1 was not able to process a
D-loop strand that was fully hybridized within the structure
(Supplementary Material, Fig. S5B, green). However, when
the D-loop strand formed a flap protruding outside of the dis-
placed DNA region, MGME1 was able to cleave the flap with
reasonable efficacy (Supplementary Material, Fig. S5B, red).
A point mutation of the conserved Lys residue of the PD-(D/
E)XK domain completely abolished all nucleolytic activities
tested (Supplementary Material, Fig. S5A, K253A). These
results suggest that effective processing of 7S DNA by
MGME1 in mitochondria would require partial unwinding of
the D-loop region, so that flap structures are generated at the 5′
ends of 7S DNA, making them accessible for the enzyme.
Loss of MGME1 results in replication-dependent
chromosomal breakage of mtDNA
Pathogenic mutations that cause mtDNA replication defects
often lead to deletions and rearrangements of the mitochondrial
genome (10). Much less is known about the role of linear frag-
ments of mtDNA in pathogenesis. Chromosomal breakage of
mtDNA near OH and OL, manifested by the presence of a
linear 11-kb double-stranded mtDNA fragment correspond-
ing to the major arc, has been associated with replication
pausing in a mouse model expressing a proofreading-deficient
mutant of the mitochondrial DNA polymerase gamma [Polg,
‘mutator mouse’, (28,29)]. It has been proposed that these
linear sub-genomic fragments are generated by spontaneous
nicking of single-stranded DNA at replication forks arrested
near OH andOL. Such fragments can also be generated by diges-
tion of normal mtDNA samples with S1 nuclease, as the junc-
tions near OH and OL are typically susceptible to nicking (29).
We examined mtDNA fromMGME1-null patient fibroblasts
by Southern blotting, and in addition to the previously reported
reduction in mtDNA copy number, we also observed an
mtDNA fragment below the expected restriction size (sub-
genomic fragment) (Fig. 3A). The size of this bandwas in agree-
ment with a potential chromosomal breakage near OH observed
previously in the mutator mouse (28,29). In order to map both
ends of the sub-genomic fragment, more detailed restriction
mapping followed by detection of mtDNA by Southern blotting
was performed in FB1976, using S1-treated DNA of normal
fibroblasts as a control (Fig. 3B and C). First, mtDNA was
digested using an enzyme with a recognition site upstream
from OH (Fig. 3B, AflII) in combination with a series of
enzymes that cut downstream of OH in the mtDNA major arc
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Figure 2.Overexpression ofMGME1modifies the steady-state levels and length of 7SDNA. (A)Western blot of a time course of expression ofMGME1.Flag.Strep2
or the K253Amutant in HEK293T cells. The MGME1 protein was detected using anti-Flag antibodies; b-actin used as a loading control. (B) Total DNA from cells
expressingMGME1wild-type or theK253Acatalyticmutant in a 4-day time coursewas analysed by 1DSouthern blottingwith a probe specific for theNCR (mtDNA
region: 14 258–4121). 18S rDNAwas used as a loading control. (C) and (D) Quantification of the Southern blots as per (A) forMGME1wild-type (B) or K253A (C).
The values of the relative DNA level (7S DNA/mtDNA—black or mtDNA/18S rDNA—grey) were normalized for the values obtained for uninduced cells. ∗∗∗P ,
0.001; two-tailed Student’s t-test; n ¼ 7 forMGME1wt, n ¼ 3 for K253A, error bars ¼ 1 SD. (E)Mapping of DNA5′ ends in the humanmtDNANCRofHEK293T
cells expressingMGME1wild-type orK253A in a4-day time course. PExwasperformedas per Figure1C. (F)TotalDNAfromcells expressingMGME1wild-type in
a6-day timecoursewasanalysedusingahigh-resolution (4%denaturingpolyacrylamidegel)1DSouthernblotwithaprobeasper (A).The7SDNAspecies containing
the DNA 5′ ends mapped by PEx in (D) are indicated. ‘Untr’—non-transfected control.
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(Fig. 3B, XhoI, BamHI, HindIII, PmeI, PstI, BglII). For each
enzyme combination, a radioactive probe that binds within the
predicted sub-genomic fragment (Fig. 3B, black bar) detected
a series of fragments consistently smaller than the genomic
restriction enzyme fragment by 1.2–1.3 kb (Fig. 3B, blue
arrowheads). On the other hand, a radioactive probe that binds
upstream of OH and outside of the predicted sub-genomic frag-
ment (Supplementary Material, Fig. S6A, black bar) did not
detect any sub-genomic bands in S1-nuclease-treated samples
nor in the MGME1-null patient fibroblasts. One end of the sub-
genomic fragment is therefore located in the vicinity of OH.
In order to determine the site of the opposite end of the sub-
genomic fragment, we performed restriction mapping using an
enzyme that cleaves in the mtDNA major arc (Fig. 3C, PmeI)
in combination with a series of enzymes that cut in the mtDNA
major and minor arc (Fig. 3C, BclI, MfeI, BglI, HindIII, NheI,
SacII, AflII and XhoI) and a radioactive probe binding in the
major arc. The sub-genomic fragment was detected in FB1976
and S1-treated fibroblasts only when a restriction enzyme cut
within the minor arc (distal to OL) was used. This localizes the
end of the fragment close to OL (i.e. between the HindIII and
NheI sites, Fig. 3C, right). Together these results indicate that
the ends of the sub-genomic species detected in the MGME1-
null patient fibroblast map nearOH andOL, and therefore, it con-
sists of the entire mtDNA major arc.
The exact nucleotide positions of the DNA ends of the sub-
genomic fragment near OL have been determined by PEx and
LM-PCR (Fig. 4A–C). The PEx analysis of OL ends in RNase
A-treated DNA samples revealed a strong pause at position
5762 in both control and patient fibroblasts, likely owing to a
hairpin secondary structure at OL reported previously (30). Add-
itional DNA 5′ ends downstream from the predicted OL hairpin
structure were detected in the FB1976 MGME1-null fibroblasts
that were not seen in control fibroblasts. These additional DNA
Figure 3. Loss ofMGME1 results in accumulation of an 11-kb sub-genomicmtDNA fragment. (A) (left) Total DNA fromHEK293T cells, control and patient fibro-
blasts (FB1976, cell passage 8) was digested with BamHI and EcoRI and analysed by 1D Southern blot with a probe specific for the NCR (mtDNA region: 16 341–
151). 18S rDNA was used as a loading control. Blue arrowhead—2.5-kb sub-1n fragment observed recurrently for FB1976. (right) Schematic representation of the
source of the sub-genomic fragment.Grey arc—the full-length genomic fragment.Empty blue arrowheads—chromosomal breakageof replication intermediates near
OH and OL. Blue arc—2.5-kb sub-1n fragment. Black bar—the probe. (B) (left) The restriction map of humanmtDNA indicating sites relevant for the analysis. Blue
arc—the sub-genomic fragment near OH. Black bar—the probe (mtDNA region: 16 341–151). (right) Total DNA from control fibroblasts treated with S1 nuclease
or fromFB1976was analysedby1DSouthernblottingusing indicated restrictases. Blue arrowheads—the sub-genomic fragments generated byS1nuclease treatment
of control cells or present in FB1976. Asterisks indicate themain genomic restriction fragmentwith residual 7SDNAstill bound (SupplementaryMaterial, Fig. S5B).
(C) (left) The restriction mapping of the sub-genomic fragments near OL (blue arc). Black bar—the probe (mtDNA region: 9 610–10 218). (right) 1D Southern blot
analysis as per (B) using restriction enzymes as indicated. The remaining indications as per (B).
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ends mapped to positions 5771 and 5772 (Fig. 4A). LM-PCR
amplification after ligation of a blunt-ended dsDNA linker to
free dsDNA ends revealed that positions 5771 and 5772 not
only mark the 5′ end of an L-strand fragment but that they
represent patient-specific free blunt ends of a double-stranded
sub-genomic fragment (Fig. 4B, Supplementary Material,
Fig. S2C). In contrast to the PEx analysis, theLM-PCRapproach
did not show any free ends in the immediate vicinity of the OL
hairpin in these conditions (position 5762), which corroborates
the assertion that the PEx signal detected at this position
results from polymerase pausing at a strong secondary structure
and does not represent true ends.
Linker-ligated DNA samples were also examined by using
an mtDNA-specific primer located close to the OH end of the
sub-genomic fragment, but outside of the 7S DNA region.
This analysis revealed that double-stranded blunt ends were
present at positions similar to those detected by PEx or
LM-PCR using primers within the 7S region (Fig. 1C and D).
While 5′ 7SDNAends close toOHwere also present in controls,
the sub-genomic fragment OH ends were specific for the
MGME1-deficient patients and were not detected in controls
(Fig. 4C).
Next, we investigated changes in the amount of the 11-kb sub-
genomic fragment in conditionsofdifferentmtDNAreplicationac-
tivity (Fig. 4D). To this end, sub-genomic fragment levels were
measured using qPCR comparing the major arc (sub-genomic+
genomic) and theminor arc (genomic) during replication inhibition
and subsequentmtDNA repopulation. InMGME1-null fibroblasts,
in accordance with measurements by Southern blotting, 20%
of FB1976 mtDNA was present as sub-genomic fragments before
ddC treatment. Similarly to full-length mtDNA, the amount of
the sub-genomic fragment decreased during replication inhibition,
although at slower kinetics (Supplementary Material, Table S1).
During recovery, the amount of sub-genomic mtDNA (Fig. 4D,
blue traces) increased parallel to total mtDNA copy numbers
(Fig. 4D, black traces). These findings suggest that the turnover
of the11-kbsub-genomic fragment isdelayed inMGME1-deficient
cells and it is de novo generated during mtDNA repopulation.
Loss of function mutations in MGME1 results in unusual
large-scale mtDNA rearrangements
Previously, we reported that patients with defective MGME1
accumulate deletions of mtDNA in affected tissues (25). The
Figure 4.Blunt ends and prolonged persistence of the 11-kb sub-genomicmtDNA fragment inMGME1-deficient fibroblasts. (A) PExmapping of DNA 5′ ends near
OL in control and FB1976.A radioactively labelled primer annealing at nt position 5915–5898 of humanmtDNAwas extended using total DNApreparations treated
withRNaseA.Right: thepredictedhairpinstructureatOLand thecurrentmodelofOL-specific initiationof lagging-strandmtDNAsynthesis (30). (B)Double-stranded
blunt ends close toOL in patient fibroblasts detected byLM-PCR.Amplificationwas performed using a linker-specific and anmtDNA-specific primer. The endswere
identified by sequencing 12 single-molecule amplicons. C1, fibroblasts from an 11-year-old healthy control; C2, fibroblasts from a 39-year-old healthy control. (C)
Double-stranded blunt ends in the vicinity of OH. Note that while 7S DNA 5
′ ends are present in this region both in patients and in controls (Fig. 1F, Supplementary
Material, Fig. S2), blunt dsDNAends are specific forMGME1-deficient patients. Positions ofmapped ends are indicated. (D) The presence of the 11-kb sub-genomic
mtDNA fragment in MGME1-deficient fibroblasts mtDNA during depletion-repopulation experiment. Fibroblasts from patients were treated with ddC for 12 days
(indicated by grey bar) followed by culturingwithout the inhibitor for 20 days. Genomic (black) and sub-genomic (blue) fragment amounts were quantified by qPCR
and normalized to copy numbers of complete ds mtDNA molecules measured at the beginning of the ddC treatment. Error bars—SD values. n ¼ 3.
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amount of apparently deleted molecules was comparable with
levels found in patients with pathogenic POLG mutations and
ranged from 0.04 to 1.5%. In contrast to POLG patients,
however, breakpoints that were consistent with unusually large
deletions spanning almost two-thirds of the mitochondrial
genome were present inMGME1 patients. To better understand
the nature of these rearranged mtDNA molecules in MGME1-
null cells, we determined exact mtDNA breakpoints by single-
molecule amplification and subsequent sequencing (Fig. 5A,
Supplementary Material, Table S2). For comparison, the
spectrum of breakpoints detected in a patient with mutated
POLG is shown in Supplementary Material, Figure S7 and
Table S3. Out of 131 detected breakpoints, only in a single case,
both breakpoints were located within the major arc (Fig. 5A,
blue arrow),wheremostmtDNAdeletions described in the litera-
ture are situated, and which is also typical for mutated POLG
(Supplementary Material, Fig. S7 and Table S3). The end posi-
tions of the other breakpoints (Fig. 5A, grey arrows) were
similar to those reported for other pathological conditions and
were mainly located between positions nt 13 000 and nt 16 100
Figure5.UnusualmtDNArearrangements inMGME1patients. (A)Circos representation of detectedmtDNAbreakpoints in patientswith pathogenicMGME1muta-
tions. Arrowheads indicate the orientation of the deletions. The part of the genome that is deleted spans counter clockwise from the root to the head of the arrow (as
indicated by dashed line in the panel ‘del’ of the scheme on the right). A detailed list of the detected breakpoints is available in Supplementary Material, Table S2.
Breakpoints that conform to regularmajor arc deletions aremarked in blue; grey arcs indicate breakpoints that removeOL. Possible interpretations of the breakpoints
are shown in the scheme on the right. del, deleted mtDNAmolecules; dup, partially duplicatedmtDNA; wt, wild-type. (B) Partially duplicated mtDNAmolecules in
skeletal muscle ofMGME1 patients as detected by long-extension PCR. The scheme on the right indicates the interpretation of the detected bands. Bands at 0.1 kb
represent short PCRfragmentsderiving fromprimers annealingat neighbouringpositions.Bandsat 0.5 kbandaboveoriginate frompartial or completeduplicationsof
mtDNA. PG_1096, 6-year-old patient with homozygous mutation R1096C in POLG; PG_748, 12-year-old patient with compound heterozygous mutationsW748S
and G848S in POLG; C1, 35-year-old healthy control; C2, 63-year-old healthy control.
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in themajor arc.However, starting positionswere locatedwithin
the minor arc and clustered either between OH and the heavy
strandpromoter (HSP), in the12S ribosomalRNAgeneordown-
stream of the tRNALeuUUR gene, which is also a binding site for
the mitochondrial transcription termination factor mTERF1
(31). The vast majority of breakpoints would be consistent
withdeletions eliminatingmore than two-thirds of themitochon-
drial genome (Fig. 5A, grey arrows) and would remove the OL
replication origin. This is notable, because it has been claimed
that OL is essential for mtDNA maintenance, and so molecules
lacking OL should be unable to propagate (32). However, we
observed clear replicative clonal expansion of many mtDNA
species with unusual breakpoints, because theywere individual-
specific and were detected many times in a single individual
(Supplementary Material, Table S2). To address the paradox
of the clonal expansion of apparently replication-incompetent
molecules, we determined whether breakpoints in the MGME1
patients could represent partial duplications instead of true dele-
tions. Investigation by long-extension PCR (Fig. 5B) showed
that, in addition to a short PCR product, large products were
also detectable in skeletal muscle samples ofMGME1 patients.
This indicates that the short primer-binding region was present
at least twice on the samemtDNAmolecule, which is a hallmark
of duplications and multiplications (Fig. 5B). Similar large
products were not detected either in control skeletal muscle
samples, or in samples from POLG patients, despite the fact
that the latter contain an increased number of regular deletions
(cf. Supplementary Material, Fig. S7 and Table S3).
Furthermore, we observed that some of the breakpoints were
associated with complex rearrangements within the NCR. In
these rearrangedmolecules, one or two short tandemduplications
of the NCRwere additionally inserted between the long-distance
breakpoints (SupplementaryMaterial, Table S1). Similar tandem
duplications of theNCRwere previously reported in humans (33)
and in a mouse model with proofreading-deficient Polg (34),
although these were of larger size. While duplications were
found to be 150–880 base pairs long in these previous studies,
we observed insertion lengths of 13–287 base pairs in skeletal
muscleofMGME1-deficient patients. Ineachcomplex rearrange-
ment, at least one breakpoint was located in a well-defined region
betweennucleotides 16 069and16 084.Anaccumulationof dele-
tion breakpoints in this specific region in the immediate vicinity
of the 3′ end of the 7S DNA has been reported in a mouse
model with elevated rates of double-strand breaks (35).
MGME1 interacts with PolgA, but not other mitochondrial
nucleoid proteins
As molecular evidence has suggested that MGME1 is required
for proper mtDNA replication, we were interested to see
whether MGME1 also physically interacts with proteins
known to be important for mtDNA metabolism. In order to
address this, a FLAG-tagged version of the protein was intro-
duced to HEK293T cells, and the FLAG tag was used to purify
MGME1 and potential interacting proteins from isolated mito-
chondria. Five bait purifications and one control purification
(from an untransfected parental HEK293T cell line) were per-
formed. Co-purified proteins were identified by high-resolution
mass spectrometry (MS) and quantified using a label-free
approach [see Supplementary Experimental Procedures for
details (36,37)]. Protein abundance was calculated as MS
signal intensity divided by the molecular mass of the protein.
Specificity was defined as the ratio of the mean signal intensity
measured in the bait purifications to the intensity determined
for the negative control purification.A complete list of identified
proteins in all 6 samples consisted of 256 proteins, which were
ranked to produce the final list (Supplementary Material,
Table S5). Components of cytoplasmic ribosomes and proteins
with specificity of ,1 were removed from the list. The final
list contains proteins which were present in all bait purifications
butwere absent from the control sample. These criteria led to the
list of potential interactors, whichwere plotted according to spe-
cificity and abundance (Fig. 6A). Additionally, we plotted the
results for trypsin, which was externally added to the samples
during MS analysis (Fig. 6A). Among the potential interactors
was PolgA, the catalytic subunit of the mtDNA polymerase
(38). Notably, we did not identify other known factors involved
in mtDNA transactions, including abundant DNA-interacting
proteins of the mitochondrial nucleoid (TFAM and mtSSB)
(Fig. 6A and Supplementary Material, Table S5). Therefore, we
decided to further study potential PolgA–MGME1 interactions.
The co-purification of PolgAwithMGME1was confirmed by
immunoblotting using a FLAG- and Strep2-tagged protein.
There was a clear enrichment of PolgA in the MGME1 elution
fraction (Fig. 6B). In contrast, there was no appreciable enrich-
ment of known DNA-interacting proteins of the mitochondrial
nucleoid (TFAMormtSSB) (Fig. 6B), confirming that a substan-
tial enrichment of PolgA had been achieved by the affinity puri-
fication procedure. In the reciprocal experiment, a tagged
version of PolgA carrying FLAG and Strep2 binding groups
(PolgA.Flag.Strep2) was expressed in HEK293T cells. PolgA.-
Flag.Strep2 and interacting proteinswere purified on a streptavi-
din column as described forMGME1.Flag.Strep2 (Fig. 6C). The
PolgA elution fraction containedMGME1, and the relative pro-
portion of eluted MGME1 was higher as compared with TFAM
or mtSSB. Elution fractions from mitochondrial extracts
obtained from parental HEK293T cells, which do not express
either of the taggedbait proteins, did not contain anyof the inves-
tigated proteins (Fig. 6D).These results suggest that a proportion
of PolgA interactswithMGME1 inhumanmitochondria, at least
in cells overexpressing these proteins.
DISCUSSION
Role of MGME1 in the metabolism of 7S DNA
The processing of the 5′ ends of 7S DNA is not a well-
characterized process. Transcription from LSP generates an
RNA molecule (7S RNA), which is thought to prime synthesis
of 7S DNA (39,40). The conserved sequence blocks (CSBs,
Fig. 1A), particularly CSB2 (nt 299–315), have been identified
as themain transition sites fromRNA toDNAsynthesis (6,7,40).
However, the major sites of the 5′ ends of 7S DNA map to sites
downstream of the CSBs [nt 191 (OH), nt 168, nt 151 and nt 110]
(6–8) suggesting that the 5′ ends of pre-7S DNA are nucleolyti-
cally processed. In our previous work, we reported that loss of
MGME1 activity, either through siRNA treatment of cultured
cells, or in fibroblasts derived frompatients with nonsensemuta-
tions in theMGME1 gene, shows an increase in the steady-state
level 7S DNA. Here, we show that abundant longer 7S DNA
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species can also be detected in these cells, the 5′ ends of which
map to immediately upstream of OH, (mtDNA nucleotide pos-
ition 191), as well as specific sites adjacent to Conserved
Sequence Block 1 (CSB1) and multiple sites at CSB2 (Fig. 1).
In MGME1-deficient cells, the longer 7S molecules could
conceivably arise from either (i) aberrant RNA–DNA transitions
or (ii) an inability to process the 5′ ends of 7S DNA molecules,
leading to an accumulation of longer species.Our experiments in-
dicate that RNA–DNA transitions are not affected in MGME1-
null cells (Supplementary Material, Fig. S3), suggesting that the
latter possibility is the case. In this scenario, theRNA–DNA tran-
sitioncouldoccuratCSB2(asobservedpreviously)or immediate-
ly upstream of CSB1 (Fig. 1), followed by MGME1-driven
exonucleolytic degradation of the 5′ ends of precursor 7S DNA
molecules to the commonly observed downstream sites at OH,
nt 171 and nt 151. This possibility is also consistent with experi-
ments in which MGME1 was overexpressed in HEK293T cells,
where shorter 7S DNA species were observed, which may result
from unusually high processing activity in these cells (Fig. 2).
The in vitro characterization of MGME1 activity has indicated
that while 5′ displaced sections of D-loop structures are good
substrates for the enzyme, fully annealed D-loop strands cannot
be degraded past the dsDNA junction (Supplementary Material,
Fig. S5A, right panel). Any precursor 7S DNA would therefore
only be a good substrate forMGME1 if its 5′ section is displaced,
although whether this is the case in vivo has not been studied.
However, the sequence at the 5′ end of the D-loop is predicted
to fold into a conserved cloverleaf-like secondary structure,
incorporating theCSB1sequence into the stemandencompassing
all of the major 5′ ends of 7S DNA observed in control cells from
this study (41). If this structure were to form in the template
L-strand following D-loop synthesis, then the 5′ end of 7S DNA
would be prevented from annealing, forming a large ssDNA
flap (Fig. 7). The Twinkle replicative helicase has been reported
to be required for 7S DNA synthesis (42), and so it also cannot
be excluded that this enzyme is responsible for unwinding the 5′
ends of 7S DNA, making them suitable for MGME1 processing.
It is less clear whether this hypothesis of direct 7S DNA pro-
cessing by MGME1 can account for the detected changes in the
steady-state levels of 7S DNAwhenMGME1 expression is per-
turbed.However, thismay be explainedwhether the length of 7S
DNA is related to its stability. Early pulse-chase experiments
Figure6. InteractionofMGME1andPolgA. (A)Mitochondria fromparentalHEK293Tcells orderivativesexpressingMGME1.Flagwere isolated, lysed, andprotein
extractswere subjected to affinity purification using anti-Flagbeads.Graphpresents quantitative analysis ofMSdata obtainedon eluates. Protein names are displayed.
MGME1, PolgA and trypsin are highlighted. The entire dataset is specified in SupplementaryMaterial, Table S5. (B)Western blot result of pull-down of the endogen-
ous PolgA with MGME1.Flag.Strep2. The mitochondrial lysates (‘Input’) and eluates (‘Elution’) were analysed with the antibodies as indicated. (C) Reciprocal
westernblot confirmationof theMGME1–PolgA interactionbyco-IPof the endogenousMGME1withPolgA.Flag.Strep2. (D)Westernblot of the control experiment
performed using parental HEK293T cells, which do not express either recombinant MGME1 or PolgA proteins.
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aimed at determining the kinetics of D-loop synthesis and turn-
over found that longer 7S DNA species in mouse cells have the
longest half-lives, suggesting that these are the most stable (43).
Longer 7S DNA molecules, such as those seen in MGME1
siRNA samples and patient fibroblasts, would therefore be
more stable and would increase in abundance. This is in line
with the observed two-fold longer in vivo half-life time of 7S
DNAinpatient fibroblasts (Fig. 1B).Shorter 7SDNAmolecules,
such as those seen in cells overexpressing MGME1, would be
less stable, consistent with their decreased abundance (Fig. 2B).
Formation and persistence of the 11-kb sub-genomic linear
dsDNA
In MGME1 patient fibroblasts, a persistent sub-genomic linear
dsDNA species was detected, the ends of which mapped to the
two classically defined replication origins, OH and OL (Fig. 3).
This species could also be generated from control human cul-
turedcells by treatmentwithS1nuclease,whichdegrades single-
stranded DNA as well as nicked double-stranded DNA (Fig. 3).
This linear species therefore appears to result from chromosome
breakage of a theta-like replication intermediate,with ends at the
replication origins. The fact that this linear dsDNA species can
be generated in control cells indicates that site-specific stalling
at the replication origins is a common occurrence in normal
human cells, as reported previously for mouse cells (29). To
our knowledge, this is the first time that such a DNA species
has been reported in a case of human mitochondrial pathology.
The 11-kb sub-genomic dsDNA species in MGME1 patient
fibroblasts persists at levels of 20% of mtDNA under steady-
state conditions. This is somewhat unexpected, because
experiments in which a restriction endonuclease was targeted
tomitochondria showed that linearmtDNA is rapidly eliminated
(44), suggesting thatmitochondria contain efficientmechanisms
to remove linear dsDNA molecules. The presence of the 11-kb
sub-genomic species under normal conditions would therefore
imply that it is constantly produced inMGME1patientfibroblasts,
likely as a by-product of replication. Consistent with this, our
results show that high levels of sub-genomic major arc fragments
accumulate inMGME1-null fibroblasts during the rapid phase of
mtDNA proliferation that accompanies recovery from mtDNA
depletion (Fig. 4D).An alternative explanation for the persistence
of the sub-genomic fragment could be thatMGME1 itself partici-
pates in the removal of linear mtDNAmolecules, although given
the strong preference of MGME1 towards ssDNA in vitro this
appears less probable.
The generation and presence of this sub-genomic fragment
could be a consequence of replication stalling per se as proposed
previously (29), or alternatively, it is possible that programmed
replication pausing occurs at OL to provide a replication check-
point. Such a checkpoint mechanism could, for example, (i)
prevent excessively damaged partially replicated molecules
from undergoing a full round of replication or (ii) assist
HSP-initiated transcription to pass the replication fork, prevent-
ing possible head-to-head collisions between mtDNA transcrip-
tion and replication. The first possibility would be consistent
with MGME1 being a part of DNA repair mechanism(s),
where the lack of MGME1 results in inability of the replisome
to restart DNA synthesis after programmed replication stalling.
This would be in line with data from the mutator mouse, where
accumulation of a high number of point mutations in the
nascent strand by the proofreading-deficient Polg also leads to
the generation of an analogous linear dsDNA species (28,29).
According to the second option, MGME1 could play a role in
preventing hazardous replication fork collisions with transcrip-
tional bubbles, similarly to other ssDNA nucleases involved in
replication of bacterial and nuclear genomes (45).
Formation of unusual mtDNA rearrangements
Most deletions ofmtDNAdescribed so far havebeen observed in
the major arc between the two classical replication origins of
mtDNA (46–48). This has led to the assumption that slipped-
strand replication is one of the main sources of mtDNA deletion
Figure 7.Hypothetical secondary structures in the D-loop region and a role for MGME1. Secondary structures are depicted as forming in the mtDNANCR region,
according to the predictions ofBrown et al. (41). Formation of a cloverleaf structure in themtDNAL-strand in theOH region could prevent the 5
′ end of 7SDNA from
annealing to the template strand, leaving7SDNAdisplacedas along5′ ssDNAflap.The regioncoveredby this cloverleaf structure encompasses almost all of themajor
sitesof7SDNA5′ ends. IfMGME1isdirectly involved in theprocessingof7SDNAends, then the5′ endof7SDNAmustbedisplaced intoan ssDNAflap inorder tobe
a good substrate forMGME1, according to the in vitro characterization presentedhere.Displacement of the 5′ endof 7SDNAbya secondary structure as shownabove
could serve this purpose.
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generation (49). Replication can, however, also play a role in
deletion formation through inducing double-strand breaks, gen-
erated at sites of stalled replication (50). If these linear DNA
molecules are not eliminated, then repair processes, acting pref-
erentially by homologous recombination, may convert them to
biochemically intact but incomplete mtDNA molecules (27).
In contrast to the predominantly major arc deletions reported in
the literature, tissue samples ofMGME1patients exhibited (in add-
ition to elevated levels of linear sub-genomicmtDNAmolecules) a
non-standard distribution of breakpoints of rearranged circular
mtDNAs, such that: (i) classical major arc breakpoints are almost
missing and (ii) 5′ starting positions were clustered in the minor
arc around the tRNAPhe gene, in the 12S ribosomal RNA gene
andclose to the tRNALeuUURgene (Fig. 5A,SupplementaryMater-
ial, TableS2). Thevastmajority of breakpoints therefore apparent-
ly seemed to remove more than two-thirds of the mitochondrial
genome. More detailed analysis revealed, however, that the
observed breakpoints originated not from classical deletions but
from partial mtDNA duplications (Fig. 5B). Similar rearranged
molecules have previously been observed in combination with
classical deletions in heart muscle of healthy individuals (51).
The fact that thebreakpoints from the apparentlyOL-lackingmole-
cules originate from replication competent duplications explains
the observed clonal expansion of these rearranged mtDNA mole-
cules. However, very surprisingly, breakpoints close to the OL
end of the prominent 11-kb linear sub-genomic fragment were
completely lacking (Fig. 5A). Thus, the 11-kb linear sub-genomic
fragment is either not recombinogenic per se, or alternatively, the
mechanism allowing homologous recombination to occur is not
properly functioning. As the first possibility does not explain the
apparent lack of other major arc deletions, the latter possibility
seems to be more likely. In this context, it is interesting to
mention that the requirement of MGME1 for homologous recom-
bination might be a consequence of its efficient 5′ end processing
activity of ssDNA substrates, and a residual 5′ end processing
activity of dsDNA substrates [cf. Fig. 3 in (25)]. It is possible
that functional interactions with a helicase in vivo allow for
unwindingdsDNAtoexpose longerstretchofssDNAfor resection.
The finding of similarly rearrangedmtDNA species in the skeletal
muscleof a transgenicmousemodel expressingadefectiveTwink-
ledup protein (52) might point towards Twinkle. As the generation
of 3′ overhangs is a prerequisite for strand invasion during double-
strand break repair by intramolecular homologous recombination
(53,54), it is tempting to speculate that this missing activity
might impair the formation of regular major arc breakpoints in
MGME1 patients. The irregular breakpoint hotspots observed in
MGME1 deficiency could be accounted for by alternative forms
of single-strand generation. Two hotspots of the detected duplica-
tion breakpoints are localized close to the D-loop, the triple-strand
structureofwhichmay facilitate single-strandannealing.Theother
hotspotwasdetectedclose to the tRNALeuUURgene,whichacts as a
binding site for the mitochondrial transcription termination factor
mTERF1 (31). The interaction of mTERF1 with mtDNA might
also create the single-stranded DNA required for the strand inva-
sion process during homologous recombination.
Functional relationship between MGME1 and PolgA
Cells with compromised MGME1 activity (either patient fibro-
blasts or siRNA-transfected cells) share a number of molecular
similarities with cells of the ‘mtDNA mutator’ mouse. This
model animal carries a homozygous knock-in mutation in the
POLG gene, encoding the catalytic subunit of the mtDNA poly-
merase,which inactivates the 3′  5′ exonucleolytic proofread-
ing activity of the enzyme. On a molecular level, mutator mice
accumulate extremely high levels of mtDNA point mutations
and low levels of multiple mtDNA deletions (28,55,56). The
similarities between MGME1-deficient and mutator mouse-
derived cells include: (i) replication stalling at multiple sites
throughout themitochondrial genome,with aparticular accumu-
lation of forks in the NCR (25,29), (ii) chromosome breakage at
OH and OL, leading to the accumulation of an 11-kb linear
dsDNA species [Fig. 3 and Fig. 4, (29)] and (iii) small tandem
insertions or deletions, especially in the NCR region [Supple-
mentary Material, Table S4, (34)]. These shared similarities,
combinedwith the findings pointing towards a potential physical
interaction of MGME1 with PolgA as shown by our proteomic
approach followed by reciprocal pull-downs (Fig. 6), suggest
that MGME1 and the 3′  5′ exonucleolytic activity of PolgA
might be involved in the same process. Below we present
some hypotheses regarding functional cooperation of MGME1
and PolgA.
In yeast, the 3′  5′ exonucleolytic activity of the lagging-
strand nuclear DNA polymerase Pold has been implicated in
the removal of ssDNA flaps in Okazaki fragments (57,58). It is
possible that the 3′  5′ exonucleolytic activity of PolgA is
also necessary for DNA flap processing. If MGME1 is involved
in the processing of 5′ ssDNAflaps arising fromDNA synthesis,
as was suggested previously (25), then many of these shared
similarities could be accounted for. An alternative hypothesis
relates to the capacity of the exonuclease-deficient Polg to
perform strand-displacement synthesis upon reaching an
upstream DNA fragment. A general feature of exonuclease-
deficient DNA polymerases is an increased strand-displacement
activity, as has been observed for T7 DNA polymerase (59), T4
DNApolymerase (60),Escherichia coliDNApolymerase II (61)
and yeast Pold (62). Based on previous data, increased strand-
displacement activity could also be a feature of the exonuclease-
deficient Polg. With this assumption, the shared similarities
could result from the formationof longerDNAflapsby increased
strand-displacement by the exonuclease-deficient Polg, or by
defects in the removal of DNA flaps in the case of MGME1
deficiency.
Little is known about what happens when forks meet to com-
plete DNA replication in any organism studied thus far. The
tandem insertions seen in the NCR of MGME1-deficient
patient fibroblasts are reminiscent of control region multimers
(CRMs) observed in the mutator mouse (34). It was suggested
that CRMsmight be indicative of problems with replication ter-
mination, which according to current models takes place in the
NCR and may involve the exonuclease activity of Polg (34). It
is plausible that the loss of exonuclease activity of Polg in the
mutator mouse or in the MGME1-deficient cells perturbs
mtDNA replication termination, manifested by multiplication
of theNCRinboth systems.This possibilitywould also addition-
ally point towards a potential role of MGME1 in mtDNA repli-
cation termination.
In summary, we provide evidence that MGME1 activity is
directly involved in the processing of 5′ ends of the 7SDNA. Fur-
thermore,we show that loss ofMGME1 leads to the accumulation
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of an11-kb linear sub-genomicmtDNAfragment, a by-product of
mtDNA replication originating from chromosome breakage at
fragile sites. This is in agreement with its direct functional in-
volvement in mtDNA replication, which is supported by the
observed direct interaction of MGME1 with the mitochondrial
replicase PolgA, suggesting that MGME1 is a constituent of the
mitochondrial replisome.Therefore,MGME1isaprobablecandi-
date to provide the replisomewith a 5′  3′ exonuclease activity
that is an inherent part of prokaryotic polymerases, but missing
from their eukaryotic counterparts. In the poxvirus, FEN1-like
nuclease, a 5′  3′ exonuclease that is necessary for seamless
replication is also reported to be involved in repair of double-
strand breaks (63). Similarly, the role of MGME1 in DNAmain-
tenance is not necessarily restricted to replication but might also
involve homologous recombination to remove undesirable free
DNA ends. This latter role is supported by the abundance of
irregular breakpoints in rearranged mtDNA molecules that are
observed upon loss of MGME1 activity.
MATERIALS ANDMETHODS
Cell culture and transfection
HeLa cells were maintained in Dulbecco’s Modified Eagle
Medium (DMEM, Invitrogen) supplemented with 10% foetal
calf serum (FCS, Thermo Scientific), 10 U/ml penicillin and
10 mg/ml streptomycin (Gibco). Fibroblast lines were cultured
as mentioned above with the addition of 50 mg/ml uridine
(Sigma). HEK293T Flp-In cells, following transfection, were
maintained in DMEM supplemented with 10% tetracycline-free
FCS(BiochromAG),10 U/mlpenicillin and10 mg/mlstreptomy-
cin (Gibco), 50 mg/ml hygromycin (Invitrogen) and 15 mg/ml
blasticidin (Invivogen).
The construction of pcDNA5/FRT/TO encoding full-length
cDNAMGME1 wild-type or K253A or PolgA with C-terminal
FLAG and Strep2 tags was as described previously (25).
HEK293T cells were stably transfected with the above-
mentioned constructs as described previously (25). For overex-
pression analysis and the pull-downs as per Figure 6B, clonal
HEK293T cell lines were induced to express MGME1 or its
K253A variant with 20 ng/ml doxycycline for the indicated
length of time. A stable cell line inducibly expressing MGME1.
FLAG for the MS experiments was described previously (26).
For siRNA-mediated down-regulation experiments, 100 000
HeLa cells were transfected using Lipofectamine RNAiMAX
(Invitrogen) with siRNA against MGME1 or negative control
(Invitrogen Stealth) for 3 days and then re-transfected for a
further 3 days. siRNA sequences used were as follows:
MGME1 siRNA 1: 5′ CGAGTCCTTCAGCAGACCATGA
CAA 3′
MGME1 siRNA 2: 5′ CCACGAAGCCTTGGAAAGCATA
CTT 3′
Restriction mapping and Southern blotting
Total DNA was isolated from fibroblast cells using a DNeasy
blood and tissue kit (Qiagen). Three micrograms of DNA was
restricted using the indicated enzymes according to manufac-
turer’s instructions (New England Biolabs). Where indicated,
samples were subsequently treated with 60 U S1 nuclease
(Promega) for 15 min at 378C. Products were separated on 0.6%
agarose gels (Invitrogen Ultrapure) and dry-blotted overnight
onto nylon membrane (GE Magnaprobe). For high-resolution
Southern blots, DNA was separated on 5% polyacrylamide gels
and electroblotted in 0.5× TBE onto nylon membrane. Mem-
branes were hybridized with appropriate radiolabelled probes
overnight at 658C in 0.25 M phosphate buffer (pH 7.6) and 7%
SDS, then washed for 3 × 20 min in 1× SSC and 0.1% SDS
and imagedusingaphosphorimager (GEHealthcare) and scanned
using a Typhoon 9410 scanner.
Primer sequences used for producing probes were as follows:
H1 probe fwd: 5′ TTACAGTCAAATCCCTTCTCGT 3′,
nt16341–16362
H1 probe rev: 5′ GGATGAGGCAGGAATCAAAGACAG 3′,
nt 128–151
mt2 probe fwd: 5′ CACTGAAAATGTTTAGACGGG 3′, nt
607–627
mt2probe rev: 5′GGCTCCTCTAGAGGGATATG3′, nt 1185–
1204
mt17probe fwd: 5′CCGTATTACTCGCATCAGG3′, nt 9610–
9628
mt17 probe rev: 5′ TTATGGAGAAAGGGACGC3′, nt 10201–
10218
18S probe fwd: 5′ GTTGGTGGAGCGATTTGTCT 3′
18S probe rev: 5′ GGCCTCACTAAACCATCCAA 3′
Primer extension
Primers were 5′ radiolabelled using T4 Polynucleotide kinase
(New England Biolabs) according to manufacturer’s instruc-
tions, annealed to 1mg total DNA and extended using Taq poly-
merase using 20 cycles of denaturation at 958C and extension at
728C. Sequencing ladderswere produced using Sequenase poly-
merase according to manufacturer’s instructions. Products were
separatedon7Murea, 5%polyacrylamide sequencing gels, dried
and imaged using a phosphorimager (GE Healthcare).
Antibodies
Primary antibodies used for western blotting were as follows:
MGME1 (Sigma HPA040913, 1 : 500 dilution), b-actin (Sigma
A2228, 1 : 300 000), PolgA (Santa Cruz, 1 : 1000), mtSSB1
(kindly donated by Dr Kang) and TFAM (kindly donated by Dr
Wiesner). Secondary antibodies used were as follows: goat anti-
rabbit HRP (Promega W401B, 1 : 2000) and goat anti-mouse
HRP (Promega W402B, 1 : 2000).
Induced mtDNA depletion and repopulation in human
fibroblasts
Fibroblasts from 5 × 5 mm skin biopsies of MGME1 patients
and healthy controls were cultivated in DMEM medium sup-
plemented with 10% foetal calf serum, 100 U/ml penicillin,
100 U/ml streptomycin, 0.05 mg/ml uridine and2mMglutamine
in a 5% CO2 atmosphere at 378C. Replication of mtDNA was
inhibited in fibroblasts by treating cells with 20 mM ddC for 12
days, after which fibroblasts were grown in normal medium
for another 20 days to enable mtDNA to repopulate the cells.
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PCR
Copy numbers of mtDNAwere determined by quantitative PCR
essentially as describedpreviously (64).Briefly, a segment of the
mtDNA in the minor arc was amplified using primers 3922F24
and 4036R26 (first number, 5′ nucleotide of primer; second
number, length of primer; F, forward primer; R, reverse primer;
numbering according to reference sequence NC_012920). A
major arc segment was amplified with primers 14588F24 and
14695R20. Primers 16520F24 and 35R24 were used to amplify
a short segment inside the 7S region of the mtDNA. CT values
were defined at the inflection points of fitted sigmoid curves
(4-parameter Chapman curves) and were compared with those
of the single copy nuclear gene Kir4.1 amplified by primers
KIR835F19 andKIR903R19 (numbering according to sequence
U52155). Reactions were performed on a MyiQ qPCR system
(Bio-Rad, Munich, Germany) using iQ SYBR Green Supermix
(Bio-Rad) under the following conditions: 958C for 7 min, and
45 cycles of 958C for 15 s and 608C for 1 min. 7S DNA copy
numbers were calculated by subtracting the apparent copy
number of the minor arc from apparent copy number of the 7S
DNA region. Sub-genomic fragment copy numbers were calcu-
lated by subtracting minor arc values from the apparent copy
numbers of the major arc. Minor arc copy number was consid-
ered as copy number of the complete mtDNA. All copy
numbers were calculated for the total growing cell mass by
multiplying per nucleus copy numbers by total cell numbers.
All other PCR techniques (single-molecule PCR, ligation-
mediated PCR and long-extension PCR) are described in Sup-
plementary Experimental Procedures.
Pull-down experiments and mass spectrometry
The expression of the FLAG-tagged version of MGME1 was
induced for 24 h with 25 ng/ml of tetracycline. Mitochondria
isolation and preparation of mitochondrial protein extracts
were performed as described previously (65) and are described
in details in Supplementary Experimental Procedures. MS ana-
lysiswas performed byLC–MS in theLaboratory ofMass Spec-
trometry (IBB PAS, Warsaw) using a nanoAcquity UPLC
system (Waters) coupled to an LTQ-Orbitrap Velos mass spec-
trometer (ThermoScientific) as previously described (37), and
the datawere analysed as detailed in SupplementaryExperimen-
tal Procedures. The pull-down experiments as per Figure 6B and
C were performed as previously described (66).
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